PharmaCyte Biotech (PMCB) Interest Coverage Ratio (2010 - 2026)
PharmaCyte Biotech (PMCB) posted quarterly Interest Coverage Ratio of 0.13 for Q2 2026, down 89.44% year-over-year from 1.23 in Q2 2025, and down 89.44% quarter-over-quarter from 0.07 in Q2 2025.
PharmaCyte Biotech (PMCB) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported Interest Coverage Ratio for 16 consecutive years, with 0.13 the latest figure, recorded in Q2 2026.
- In Q2 2026, Interest Coverage Ratio fell 89.44% year-over-year to 0.13; the TTM figure through Apr 2026 stood at 0.35 (down 23.06% YoY), while the FY2026 annual figure was 0.35, down 23.04% from the prior year.
- Interest Coverage Ratio retreated to 0.13 in Q2 2026 per PMCB's latest filing, from 0.07 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 312.85 in Q1 2023 and bottomed at 1001.13 in Q4 2022.
- Historically, Interest Coverage Ratio has averaged 188.61 across 5 years, with a median of 0.21 in 2024.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio sank 585.46% — and 2023, when it surged 255.42%.
- PharmaCyte Biotech's Interest Coverage Ratio stood at 1001.13 in 2022, then surged by 131.25% to 312.85 in 2023, then tumbled by 100.07% to 0.21 in 2024, then jumped by 67.15% to 0.07 in 2025, then sank by 89.44% to 0.13 in 2026.
- Business Quant data shows PMCB's Interest Coverage Ratio at 0.13 in Q2 2026, 0.07 in Q2 2025, and 0.21 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | PharmaCyte Biotech | 4.30 Mn | 4.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -0.13 |
| Apr 30, 2025 | -0.07 |
| Apr 30, 2024 | -0.21 |
| Jan 31, 2023 | 312.85 |
| Oct 31, 2022 | -1,001.13 |
| Jul 31, 2022 | -430.26 |
| Jan 31, 2022 | -201.30 |
| Oct 31, 2021 | -146.05 |
| Jul 31, 2021 | -639.59 |
| Apr 30, 2021 | -3,965.30 |
| Jan 31, 2021 | -201.08 |
| Oct 31, 2020 | -184.59 |
| Jul 31, 2020 | -70.78 |
| Apr 30, 2020 | -1,655.39 |
| Apr 30, 2019 | -0.08 |
| Jan 31, 2019 | -35.05 |
| Apr 30, 2017 | -2,390.35 |
| Jan 31, 2017 | -9,786.37 |
| Oct 31, 2016 | -2,736.50 |
| Jul 31, 2016 | -1,812.65 |